Showing results (311-320 of 542) with videos related to
Sort By:
Pageof 55
Neurodegenerative Disease Management|November 19, 2014
Role of citalopram in the treatment of agitation in Alzheimer's diseaseAnton P Porsteinsson, Melanie A Keltz, Jessica S SmithNeurodegenerative Disease Management|November 19, 2014
The sleep-wake cycle and Alzheimer's disease: what do we know?Miranda M Lim, Jason R Gerstner, David M HoltzmanNeurodegenerative Disease Management|October 15, 2014
Decision-making impairments in Parkinson's disease as a by-product of defective cost-benefit analysis and feedback processingAgata Ryterska, Marjan Jahanshahi, Magda OsmanNeurodegenerative Disease Management|September 2, 2020
Efficacy and safety of mexiletine in amyotrophic lateral sclerosis: a systematic review of randomized controlled trialsKaren Joy Adiao, Adrian Espiritu, Marjorie Anne BagnasNeurodegenerative Disease Management|February 8, 2020
Effects of a community-based exercise program on mobility, balance, cognition, sleep, activities of daily living, and quality of life in PD: a pilot studyMelanie Tidman, Erin SkotzkeNeurodegenerative Disease Management|January 19, 2019
Newest evidence for tetrahydrocannabinol:cannabidiol oromucosal spray from postapproval pragmatic studiesFrancesco PattiNeurodegenerative Disease Management|January 27, 2018
Understanding important issues in young-onset dementia care: the perspective of healthcare professionalsJohn H Spreadbury, Christopher M KippsNeurodegenerative Disease Management|May 19, 2022
Glutamate modulation for the treatment of levodopa induced dyskinesia: a brief review of the drugs tested in the clinicImane Frouni, Philippe HuotNeurodegenerative Disease Management|July 21, 2021
A survey on patients' disease perception and the impact of the COVID-19 pandemic on persons living with amyotrophic lateral sclerosis in MalaysiaSuzanna Edgar, Nur Adilah Abdul-Aziz, Ee Chin Loh, et al.Neurodegenerative Disease Management|July 7, 2021
Adjusting the Thai version of the Addenbrooke's Cognitive Examination III for education to screen for dementiaThammanard CharernboonPageof 55